Objective The prescription opioid epidemic is currently responsible for the greatest quantity of unintentional deaths in the United States. the PDMP such as usability and also their own clinical gestalt impression when deciding to use PDMPs for a given patient encounter. Providers use the information in PDMPs to alter clinical decisions and guideline opioid prescribing patterns. Physicians describe option uses for the databases such as improving their ability to facilitate discussions on addiction and provide patient education. Conclusion PDMPs are used for multiple purposes including identifying opioid misuse and enhancing provider-patient communication. Given variance in practice requirements may help direct indication and manner of physician use. Steps to minimize administrative barriers to PDMP access are warranted. Finally alternate PDMP uses should be further analyzed to determine their appropriateness and potentially expand their role in clinical practice. set of codes to ensure that we recognized specific constructs that resolved our research question as well as a set of Peptide YY(3-36), PYY, human codes that Peptide YY(3-36), PYY, human emerged from the data de novo. Four investigators (A.S.K. B.P. S.M.G. Z.F.M.) developed the set of grounded theory codes from a line-by-line reading of the text. The entire team of investigators examined the code list. Peptide YY(3-36), PYY, human Nine thematic nodes specifically pertained to PDMPs: access awareness frequency of use pattern of use obstacles unfavorable opinion positive opinion use in confronting patients and patient reactions. Each code was defined and then applied to all transcripts by two study investigators (A.S.K S.M.G). In terrater reliability was assessed periodically with the function in NVivo designed for this purpose with interrater agreement surpassing 90%. Discrepancies in coding were discussed and resolved by consensus. Two investigators (R.J.S. Z.F.M.) summarized codes Peptide YY(3-36), PYY, human and examined associations among codes to develop a theory about the data. Funding Financial support for this study was provided in part by grants from your Agency for Healthcare Research and Quality Patient-Centered Outcomes Research and the National Institutes of Health Career Development. The funding agreement ensured the authors’ independence in designing the study interpreting the data writing and publishing the statement. Prior Work The content of these interviews was previously analyzed by Kilaru et al to inform a manuscript on emergency medicine physician perspectives related to opioid guidelines. (21) We have adapted portions of our methods section from their study. Results Characteristics of Study Subjects Table 1 explains the characteristics of our study subjects. The participants varied demographically across age sex years of practice and geographic location. Table 1 Participant characteristics Peptide YY(3-36), PYY, human (N=61) Interview Domains and Themes We organized the interview content about PDMPs into three broad domains: (1) barriers and facilitators to PDMP access; (2) frequency and triggers for PDMP use; and (3) option PDMP uses. Within each domain name we developed key themes as offered below. Table 2 summarizes the key themes as well as representative quotations from interview participants. This table also presents testable hypotheses and future research questions that can be derived from these themes. Rabbit Polyclonal to CCDC102B. Table 2 Domains Themes Representative Interview Estimates and Research Hypotheses from Emergency Department (ED) physicians regarding Prescription Dug Monitoring Programs (PDMPs) Barriers and Facilitators to PDMP Use: Awareness Hurdles & Access Awareness of PDMPs ranged broadly among providers with some lacking previous knowledge of PDMPs as well as others having an elaborate understanding of their state’s PDMP. Among those who were aware of their state’s PDMP many physicians noted that ease of PDMP access determines use. Providers cited many logistical and administrative hurdles to using their PDMP. Registering for and gaining initial permission to access the state PDMP often requires the physician to total administrative tasks. Physicians noted that this process could be cumbersome and that it limited physician engagement with the database. Once an individual is usually registered logging into the system is usually noted as complicated and time-consuming. Furthermore lack of use of the PDMP can lead to user expulsion from the system thereby requiring re-registration. As one physician notes “You can’t just get access to it you have to get a notarized form and go through a lot of different actions.